Vaxil Provides Update on USAMRIID, Oral Experiment and Other General Business Matters
27 janv. 2021 07h50 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil’s Annual and Special Shareholders Meeting and Update on Exercise of Warrants
31 déc. 2020 16h10 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 31, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
VAXIL Provides Update on USAMRIID and Oral Experiments
29 déc. 2020 16h10 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Retains Investor Engagement and Marketing Firm
22 déc. 2020 07h50 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Close of Second and Final Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $264,100
10 déc. 2020 07h50 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Business Update on Corvax™ Experiments
03 déc. 2020 07h55 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Close of First Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $542,858
24 nov. 2020 07h00 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Non-Brokered Private Placement
09 nov. 2020 10h19 HE
|
Vaxil Bio Ltd.
NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Enters Into a Cooperative Research and Development Agreement With U.S. Army Medical Research Institute of Infectious Diseases (“USAMRIID”)
26 oct. 2020 11h57 HE
|
Vaxil Bio Ltd.
NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Oct. 26, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Initiates Pre-Clinical Study in New Oncology Target
13 oct. 2020 07h30 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...